Vladimir Vexler
Net Worth
Last updated:
What is Vladimir Vexler net worth?
The estimated net worth of Mr. Vladimir Vexler is at least $6,976,919 as of 9 Mar 2021. He owns shares worth $57,123 as insider, has earned $3,077,446 from insider trading and has received compensation worth at least $3,842,350 in Coherus BioSciences, Inc..
What is the salary of Vladimir Vexler?
Mr. Vladimir Vexler salary is $768,470 per year as Chief Scientific Officer in Coherus BioSciences, Inc..
How old is Vladimir Vexler?
Mr. Vladimir Vexler is 67 years old, born in 1958.
What stocks does Vladimir Vexler currently own?
As insider, Mr. Vladimir Vexler owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Coherus BioSciences, Inc. (CHRS) | Chief Scientific Officer | 53,386 | $1.07 | $57,123 |
What does Coherus BioSciences, Inc. do?
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; and CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Vladimir Vexler insider trading
Coherus BioSciences, Inc.
Mr. Vladimir Vexler has made 3 insider trades between 2020-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 114,240 units of CHRS stock on 9 Mar 2021. As of 9 Mar 2021 he still owns at least 53,386 units of CHRS stock.
Coherus BioSciences key executives
Coherus BioSciences, Inc. executives and other stock owners filed with the SEC:
- Mr. Dennis M. Lanfear (70) Chairman, Pres & Chief Executive Officer
- Mr. Vladimir Vexler (67) Chief Scientific Officer